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Objectives: Our objective was to determine the relationship between functional out-
come and abnormalities of heart rate and rhythm after the Fontan operation.
Methods: The National Heart, Lung, and Blood Institute Pediatric Heart Network con-
ducted a cross-sectional analysis of patients who had undergone a Fontan procedure at
the 7 network centers. Analysis was based on 521 patients with an electrocardiogram
(n 5 509) and/or bicycle exercise test (n 5 404). The Child Health Questionnaire
parent report and the oxygen consumption at the anaerobic threshold were used
as markers of functional outcome.
Results: Various Fontan procedures had been performed: intracardiac lateral tunnel
(59%), atriopulmonary connection (14%), extracardiac later tunnel (13%), and extrac-
ardiac conduit (11%). Prior volume unloading surgery was performed in 389 patients:
bidirectional Glenn (70%) and hemi-Fontan (26%). A history of atrial tachycardia was
noted in 9.6% of patients and 13.1% of patients had a pacemaker. Lower resting heart
rate and higher peak heart rate were each weakly associated with better functional sta-
tus, as defined by higher anaerobic threshold (R 5 20.18, P 5 .004, and R 5 0.16,
P5 .007, respectively) and higher Child Health scores for physical functioning (R5
20.18, P, .001, and R5 0.17, P5 .002, respectively). Higher anaerobic threshold
was also independently associated with younger age and an abnormal P-axis. Resting
bradycardia was not associated with anaerobic threshold or Child Health scores.
Conclusions: In pediatric patients (6–18 years) after the Fontan procedure, a lower
resting heart rate and a higher peak heart rate are each independently associated
with better physical function as measured by anaerobic threshold and Child Health
scores. However, these correlations are weak, suggesting that other, nonrhythm and
nonrate, factors may have a greater impact on the functional outcome of pediatric
patients after the Fontan operation.
H
eart rate and rhythm disorders, such as sinus node dysfunction and atrial
tachycardia, are common and potentially important late morbidities of the
Fontan operation.1-10 The incidence of late sinus node dysfunction after
the Fontan operation has been reported to be about 15%1-3 but may occur in up to
44% of patients in selected series.4 The incidence of atrial tachycardia is 16% to
17% at approximately 5 years after the Fontan procedure1,5 and reaches 50% by 12
years.1 Further, sinus node dysfunction and atrial tachycardia can result in significant
symptoms and comorbidities necessitating interventions, including medication,11
pacing,12 catheter ablation,13 and surgery,14 and may also be associated with an
increased risk for late death.7,12,15,16 However, little is known about the impact of
heart rate and rhythm disorders on the daily lives of pediatric patients who have
undergone the Fontan operation.
The goal of this study was to analyze heart rate and rhythm data from a large group
of Fontan patients studied with a uniform protocol to define the incidence of heart rate
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DAbbreviations and Acronyms
ECG 5 electrocardiogram
CHQ 5 Child Health Questionnaire
CHQ-PF50 5 Child Health Questionnaire Parent Report
CHQ-p 5 Child Health Questionnaire—physical
CHQ-ps 5 Child Health Questionnaire—psychosocial
VAT 5 oxygen consumption at anaerobic threshold
and rhythm abnormalities in this patient population and to
determine the impact of these abnormalities on quantifiable
measures of functional outcome.
Methods
Fontan Cross-Sectional Study
This report is based on data from the Fontan Cross-Sectional
Study executed by the Pediatric Heart Disease Clinical Research
Network of the National Heart, Lung, and Blood Institute. The
primary aim of this main study was to assess the correlation be-
tween functional health status and measures of ventricular perfor-
mance in children aged 6 to 18 years who have undergone
a Fontan procedure. Details regarding the structure of the Pediat-
ric Heart Network and the general methods of the Fontan Cross-
Sectional Study have been reported previously.17 Informed
consent was obtained and data were collected at each of the par-
ticipating centers according to the rules of each institution’s inter-
nal review board.
Heart rate, heart rhythm, and functional analysis—Patient
sample. A total of 546 subjects were enrolled in the Fontan
Cross-Sectional Study. Twenty-five patients were excluded from
this analysis of heart rate and rhythm: In 17, neither an electrocar-
diogram (ECG) nor an exercise test was available; 7 had under-
gone surgical conversion of the Fontan circuit, which may have
had an impact on arrhythmia development14; and 1 had second-
degree atrioventricular block, leaving 521 subjects in the analytic
data set.
Some additional exclusions were applied for selected heart rate
and rhythm analyses. Patients with a pacemaker may have had
a falsely elevated heart rate at rest and during exercise, whereas
patients receivinging antiarrhythmic drugs may have had a falsely
lowered heart rate. Thus the physiologic relationship between
underlying heart rate and outcome in these patients might not be
accurately identified. To avoid this possibility, we excluded from
all heart rate analyses 34 subjects with a rate-responsive pacemaker
(n 5 5) and/or subjects who were currently treated with beta-
blockers or class III antiarrhythmics (n 5 30), and we excluded
43 subjects with a paced rhythm on resting ECG from the resting
heart rate analysis.
Functional outcome measures. The Child Health Question-
naire (CHQ) Parent Report (CHQ-PF50) and the oxygen consump-
tion (volume O2 $ kg
21 $ min21) at the anaerobic threshold (VAT)
during exercise testing were used as measures of functional out-
come. The CHQ-PF50 provides physical (CHQ-p) and psychoso-
cial (CHQ-ps) summary scores to describe the well-being of
children 5 to 18 years of age.18 This instrument has been used
extensively to establish functional outcome in normal children asThe Journal of Thorwell as pediatric patients with various diseases and is among the
most reliable tools for this purpose.19 For this study, VAT was
used as the marker for exercise performance because it is less effort
dependent than other measures and reflects performance at lower
levels of exercise.
ECG. A standard 12-lead ECG was performed in the supine
position and recorded at 25-mm/s sweep speed with a 10 mm/
mV-amplitude. All ECGs were performed at supine rest and before
any exercise testing. Bradycardia was defined as a resting heart rate
less than the fifth percentile for age.20
Exercise testing. A 12-lead ECG was continuously monitored
during the exercise protocol. Arterial oxygen saturation was mea-
sured transcutaneously at rest and continuously during exercise.
Maximal exercise testing was performed with a standard ramp pro-
tocol on an electronically braked cycle ergometer.21
Oxygen consumption and carbon dioxide production were mea-
sured continuously. VAT was measured by the V-slope method in
those children in whom it could be accurately determined.
Peak heart rate percent predicted of normal for age was calcu-
lated as (peak heart rate/[220 2 age]) 3 100. Chronotropic index22
was calculated as (peak heart rate 2 resting heart rate)/(0.925 3
[220 2 age 2 resting heart rate]).
Statistical Analysis
Groups were defined by resting heart rate less than fifth percentile,
peak heart rate less than 75% of predicted for age, history versus
no history of atrial tachycardia, and current versus no pacemaker
use. A Fisher exact test was used when comparing the distributions
of a categorical variable by group and the Wilcoxon rank sum test
was used for comparison of the distribution of most continuous vari-
ables. The Student t test was used to compare the distributions
of resting heart rate. The Pearson rank correlation coefficient
was used to estimate the association between pairs of continuous
measures. Multivariate linear regression was used to identify
independent predictors of functional outcome, defined as VAT
and CHQ-p (physical) summary score.
Results
Enrollment, Demographics, and History
Of the 521 subjects in the analytic cohort, 509 had a supine
ECG, 404 completed a bicycle exercise test with VAT mea-
sured in 311, and 489 had analyzable CHQ-p summary
scores.
Table 1 displays patient demographics. The mean age at
enrollment was 11.96 3.4 years (median 11.3) and at the Fon-
tan procedure was 3.4 6 1.9 years (median 2.8). There were
more male (61%) than female patients. Of 389 patients who
had undergone a staged second procedure, many more (70%)
underwent the bidirectional Glenn than the hemi-Fontan. The
intracardiac lateral tunnel was the most frequent form of Fon-
tan procedure seen in these patients (59%), with the 3 other ma-
jor forms being equally distributed among the remainder of the
patients. Sixty-eight (13%) patients had a pacemaker at the
time of the study. Fifty (10%) patients had a history of atrial
tachycardia, defined as atrial tachycardia noted in the medical
record or present on the study ECG or exercise test.acic and Cardiovascular Surgery c Volume 136, Number 1 101
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Resting rhythm. Sinus rhythm was the predominant
rhythm on the resting supine ECG in only 69% of patients
(Figure 1). Among 470 patients with a P wave on the ECG,
20% had a low right atrial rhythm and 5% had a left atrial
focus. Although 13% of patients had a pacemaker, during
the resting supine ECG, only 63% of these were paced in
the following modes: AAI(R) (69%), DDD(R) (28%), or
DDIR (3%).
Resting heart rate. After appropriate exclusions (see
Methods), the average resting heart rate on ECG was 76 6
16 beats/min. Resting heart rate decreased slightly with age
(R 5 20.15, 95% confidence interval 20.24 to 20.06; P
5 .001). Over one quarter (27%) of patients had a resting
heart rate below the fifth percentile for age, but only 0.7%
had resting heart rates above the 95th percentile for age.
Patients with resting heart rates less than the fifth percentile
for age were less likely to be in sinus rhythm and more likely
to be in junctional escape rhythm than those patients with
resting heart rates greater than the fifth percentile for age
(67% vs 79% in normal sinus rhythm and 16% vs 3% in junc-
tional rhythm, respectively; P , .0001).
Peak heart rate. The average peak heart rate during exer-
cise testing in 371 patients was 157 6 21 beats/min and was
not associated with age (R 5 0.07, 95% confidence interval
20.04 to 0.17; P 5 .211). Low peak heart rate, defined as
TABLE 1. Fontan cross-sectional study patient characteristics
for 521 subjects with an ECG or undergoing an exercise test
Characteristic n Result
Age at enrollment, y (median) 521 11.9 6 3.4 (11.3)
Age at Fontan procedure,
y (median)
521 3.4 6 1.9 (2.8)
Male 521 315 (60.5%)
Race 519
White 411 (79.2%)
African American 55 (10.6%)
Asian 14 (2.7%)
Other 39 (7.5%)
Type of volume unloading
operation
389
Bidirectional Glenn 272 (69.9%)
Hemi-Fontan 101 (26.0%)
Other 16 (4.1%)
Fontan type 521
Atriopulmonary connection 72 (13.8%)
Intracardiac lateral tunnel 307 (58.9%)
Extracardiac lateral tunnel 62 (11. %)
Extracardiac conduit 69 (13.2%)
Other 11 (2.1%)
Current pacemaker 521 68 (13.1%)
History of atrial tachycardia 521 50 (9.6%)
ECG, Electrocardiogram.102 The Journal of Thoracic and Cardiovascular Surgery c Julless than 75% of predicted for age, was observed in 41% of
patients. Mean change in heart rate (peak minus resting)
was 83 6 26 beats/min, and the mean chronotropic index
(n 5 340) was 0.67 6 0.19 (median 0.70), with 73% having
an abnormally low chronotropic index less than 0.8.
Multiple heart rate and rhythm abnormalities. Many
subjects had multiple heart rate and rhythm abnormalities.
Nine percent had a resting heart rate below the fifth percentile
for age and nonsinus rhythm on resting ECG, and 10.9% had
a resting heart rate below the fifth percentile for age plus
a peak heart rate below 75% of predicted. However, 61%
of the 96 patients who had a resting heart rate below the fifth
percentile for age had a peak heart rate 75% of predicted or
greater.
Functional Outcomes
Mean CHQ-p and CHQ-ps for the group were lower than
those for historical healthy controls: CHQ-p was 45.4 6
11.8 (median 49.3) versus 53.0 6 8.8 for historical controls
and CHQ-ps was 47.3 6 10.9 (median 48.9) versus 51.2 6
9.1 for historical controls.18,19 Mean VAT was low at 18.8
6 6.4 mL $ kg21 $ min21.
Associations with Oxygen Consumption at the
Anaerobic Threshold (VAT)
VATwas measured in 311 subjects. Higher VATwas weakly
associated with lower resting heart rate (R 5 20.18, 95%
confidence interval 20.27 to 20.09; P 5 .004; Figure 2,
A) and higher peak heart rate (R 5 0.16, 95% confidence
interval 0.04 to 0.27; P 5 .07; Figure 3, A). When the
Atrial Escape
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Figure 1. Predominant rhythm on resting ECG in 509 survivors of
the Fontan procedure aged 12 6 3 years.y 2008
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Figure 2. Resting heart rate and func-
tional outcome in survivors of the
Fontan procedure. AT, Anaerobic
threshold; CHQ Physical, Child Health
Questionnaire (Parent Report) Physical
Summary score; VO2, oxygen consump-
tion; HR, heart rate.association between continuous predicted peak heart rate and
VAT was examined, the strength and significance of the
association was similar to the association between raw peak
heart rate and VAT.
VAT was not associated with bradycardia (resting heart
rate below the fifth percentile for age) or the presence of an
atrial pacemaker (Table 2). Although patients with an abnor-
mal P-axis had a higher VAT than those with a normal axis
(20.7 6 6.8 vs 18.4 6 6.2 mL $ kg21 $ min21; P 5 .02),
VAT did not differ by predominant rhythm, including junc-
tional rhythm, on resting ECG. VAT did not differ by history
of atrial tachycardia status or by the use of antiarrhythmic
medication. A multivariate model for VAT (n 5 251) using
age, rate, and rhythm variables demonstrated that younger
age (0.77 mL $ kg21 $ min21 increase per 1-year decrease
in age; P , .001), lower resting heart rate (0.91 mL $ kg21
$ min21 increase per 10 beats/min decrease at rest; P ,
.001), higher peak heart rate (0.44 mL $ kg21 $ min21
increase per 10 beats/min increase during exercise; P 5
.03), and an abnormal P-axis (2.59 mL $ kg21 $ min21
decrease if P-axis is between 0 and 90 degrees; P 5 .004)
were independent predictors of better performance and
accounted for 20% of the variation in VAT. Furthermore,
the association between age and resting and peak heart rate
was observed at all ages, without a difference between age
groups (interaction P values .77 and 0.41, respectively).
Associations with CHQ-p Score
Patients with lower resting heart rates had higher CHQ-p
scores, reflecting better functional outcome (R 5 20.18,The Journal of Tho95% confidence interval 20.27 to 0.09; P , .001; Figure 2,
B). However, bradycardia was not specifically related to
CHQ-p, since mean CHQ-p was similar for patients with
a resting heart rate at or above versus below the fifth percen-
tile for age (Table 2). Patients with a higher peak heart rate
had higher CHQ-p scores (R5 0.17, 95% confidence interval
0.06 to 0.27; P 5 .002; Figure 3, B). When the association
between continuous predicted peak heart rate and CHQ-p
score was examined, the strength and significance of the
association was similar to the association between raw peak
heart rate and CHQ-p score. Greater changes in heart rate
(peak heart rate minus resting heart rate) were associated
with higher CHQ-p scores (R5 0.19, 95% confidence inter-
val 0.08 to 0.29; P , .001). The presence of an atrial pace-
maker was associated with a lower mean CHQ-p score, as
was a positive history of atrial tachycardia (Table 2). Patients
who were treated with beta-blockers or class III antiarrhyth-
mic agents had lower CHQ-p scores than those who were not
treated with these medications (38.3 6 15.9 vs 45.9 6 11.3;
P 5 .005). Other than having a paced rhythm on resting
ECG, predominant rhythm, including junctional rhythm,
was not associated with a lower CHQ-p. A multivariate
model for CHQ-p score (n 5 324) using age and rate and
rhythm variables demonstrated that resting heart rate (8.1-
point increase in CHQ-p score per 10 beats/min decrease at
rest; P 5 .02) and peak heart rate (7.0-point increase in
CHQ-p score per 10 beats/min increase during exercise;
P5 .01) were both independent predictors of CHQ-p. How-
ever, these variables accounted for only 4% of the variation in
CHQ-p scores. Age, predominant rhythm, a history of atrial
tachycardia, the presence of a pacemaker, and the changeracic and Cardiovascular Surgery c Volume 136, Number 1 103
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Figure 3. Peak heart rate and functional
outcome in survivors of the Fontan pro-
cedure. AT, Anaerobic threshold; CHQ
Physical, Child Health Questionnaire
(Parent Report) Physical Summary
score; VO2, oxygen consumption; HR,
heart rate.from resting to peak heart rate were not independently asso-
ciated with CHQ-p after accounting for resting and peak heart
rate.
Associations with CHQ-ps Score
None of the heart rate and rhythm variables were associated
with CHQ-ps.
Discussion
This study provided a unique opportunity to analyze the
associations of heart rate and rhythm with functional out-
come in a large group of patients who had undergone the
Fontan operation at 7 centers during a relatively uniform sur-
gical era. The study offers new insight into the potential
impact of these factors on the daily lives of Fontan patients.
The specific new findings in this study are as follows: (1) rest-
ing heart rate as a continuous measure was inversely related
to functional outcome measured by VAT and CHQ-p; (2)
bradycardia (resting heart rate , fifth percentile for age)
was not related to poor functional outcome; and (3) although
lower than normal, peak heart rate during exercise was posi-
tively correlated with both VAT and CHQ-p. Additionally,
this large sample, with its well-defined criteria for heart rate
and rhythm abnormalities, provides a more accurate descrip-
tion of the prevalence of rate and rhythm abnormalities in
patients who have undergone the Fontan procedure than
has been previously available.
Heart Rate and Functional Outcome
The most intriguing finding in this study is that, independent
of age, lower resting heart rate was not associated with wors-104 The Journal of Thoracic and Cardiovascular Surgery c Julened functional outcome. Since heart rate normally falls with
age and outcome usually worsens with age, the relationship
between resting heart rate and outcome should be even stron-
ger if age-adjusted heart rates were available for use or could
be accurately derived from existing data. Further, despite
a large number of patients with bradycardia, defined as a rest-
ing heart rate less than the fifth percentile for age, bradycardia
was not associated with decreased functional status. On the
surface, this finding appears to be at odds with previous
studies that have associated sinus node dysfunction with
lower physical performance. Sinus node dysfunction has
often been broadly defined as various combinations of the
following: nonsinus rhythm on resting ECG, low resting
heart rate, low peak heart rate response to exercise, or long
pauses.1-12,15,16,23,24 However, these prior studies have typi-
cally not separately analyzed the individual components
of sinus node dysfunction, perhaps accounting for the
differences with the findings in the present study.
One possible explanation for the association between rest-
ing heart rate and functional outcome is that a high resting
heart rate is an indicator of a poor functional state, perhaps
resulting from low cardiac output and reflex sympathetic
stimulation. Conversely, we speculate that a low resting heart
rate may confer mechanical advantages to the Fontan ventri-
cle. This may be related to longer diastolic filling times sup-
porting the preload dependency of the Fontan circulation or
to improvement in load-independent diastolic mechanics.
Of note, very few patients had a resting heart rate above
the 95th percentile for age. The data in this study do not
address whether a low resting heart rate is part of a compen-
satory mechanism; however, previous authors have proposedy 2008
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DTABLE 2. Heart rate and rhythm associations with oxygen consumption at the anaerobic threshold (VAT) and Parent Report
Child Health Questionnaire Physical Summary Score (CHQ-p)
n VAT (mL $ kg21 $ min21) n CHQ-p
Resting heart rate
,5th percentile for age 75 20.1 6 6.9 (median 19.2) 117 48.1 6 8.4 (median 50.0)
$5th percentile for age 185 18.8 6 6.3 (median 17.6) 302 45.2 6 12.0 (median 48.7)
P .137 .154
Peak heart rate
,75% of predicted for age 98 18.5 6 6.2 (median 18.0) 142 45.3 6 11.3 (median 18.0)
$75% of predicted for age 191 19.2 6 6.4 (median 17.9) 210 47.8 6 9.7 (median 50.3)
P .539 .082
Current pacemaker 41 18.1 6 5.9 (median 17.0) 61 40.8 6 14.1 (median 45.0)
No current pacemaker 270 18.9 6 6.5 (median 18.1) 428 46.0 6 11.3 (median 49.5)
P .509 .007
History of AT 30 17.2 6 6.7 (median 15.7) 45 38.8 6 15.0 (median 45.2)
No history of AT 281 19.0 6 6.4 (median 18.1) 444 46.0 6 11.3 (median 49.8)
P .081 .0008
Abnormal P-axis 64 20.7 6 6.8 (median 19.1) 110 43.3 6 12.7 (median 46.4)
Normal P-axis 214 18.4 6 6.2 (median 17.4) 334 46.0 6 11.1 (median 49.6)
P .015 .071
Nonsinus rhythm 89 19.8 6 6.5 (median 18.0) 146 44.1 6 12.9 (median 48.2)
Sinus rhythm 210 18.6 6 6.4 (median 17.8) 333 45.7 6 11.3 (median 49.5)
P .183 .394
AT, Atrial tachycardia.that resting bradycardia in Fontan patients may be more
likely to be the result of surgical or functional autonomic
derangements, with selective reduction of cardiac sympa-
thetic activation rather than sinus node dysfunction.25 Any
link between autonomic function and the association between
higher CHQ-p score and lower heart rate will need to be sub-
stantiated in further studies.
The role of peak heart rate in these patients may be more
complex. It is clear that the population had an abnormal heart
rate response to exercise, with 73% of subjects having an
abnormally low chronotropic index. The chronotropic index
may be a better representation of the expected peak heart rate
response to exercise than the formula (peak heart rate 5 220
2 age [years]).22 It is less clear whether the abnormal chro-
notropy is due to intrinsic sinus node dysfunction, autonomic
derangements, or other mechanisms. Regardless of the etiol-
ogy, a higher peak heart rate was associated with a higher
VAT and a higher CHQ-p. Although this relationship was
found to be weak in this group of Fontan patients, its exis-
tence is no different from that in patients with normal
hearts,26 in whom increasing heart rate is the most important
mechanism for augmenting cardiac output during exercise.
Although other studies have demonstrated that pacing is
indicated in Fontan patients with symptomatic bradycar-
dia,1,3,4 the clinical message from this study might be that
good functional outcomes in patients with low resting heart
rates suggests that placement of a pacemaker for asymptom-
atic bradycardia might not improve clinical status and may
warrant very careful reconsideration. Inasmuch as a higherThe Journal of Thopeak heart rate was also correlated with better functional out-
come, failure to increase heart rate during exercise may be
a better indicator of pacemaker necessity, but this needs to
be evaluated in a prospective manner.
Heart Rate and Rhythm Abnormalities
Despite the more recent surgical era represented in the pres-
ent study, the high incidence of heart rate and rhythm abnor-
malities in this Fontan population is consistent with that
reported by previous authors.1-10 In the present study, 27%
of patients had resting heart rates below the fifth percentile
for age, 31% had a nonsinus rhythm on resting ECG, and
41% had a peak heart rate less than 75% of predicted. Previ-
ous studies defined sinus node dysfunction as having any one
of these abnormalities,1-3 with a prevalence of up to 44% in
select series.4 Fishberger and associates7 reported that 9.2%
of Fontan patients had a pacemaker after a mean follow-up
of 6 years, similar to the 13% prevalence during a follow-
up of about 8.5 years in this study. Interestingly, the inci-
dence of atrial tachycardia in the present study was lower
than reported in prior studies despite a longer follow-up
period (9.6% at 8.5 years compared with 16% to 17% at 5
years).1,5 Thus the impact of the more recent era may have
been greater on the development of atrial tachycardia than
on other heart rate and rhythm abnormalities.
Limitations
Despite the important findings presented here, this study has
several limitations. First, since the study was observational,racic and Cardiovascular Surgery c Volume 136, Number 1 105
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Second, although this study suggests that lower resting and
higher peak heart rates may be beneficial in Fontan patients,
these variables accounted for only 8% of the variance in
CHQ-p, indicating that other factors may be more important
in determining CHQ-p than heart rate. Third, the associations
found between heart rate and CHQ-p or VAT arose from
a subsample of the study cohort, which excluded patients
who were paced and those receiving antiarrhythmic medica-
tion. Inasmuch as the study design did not allow for the
reprogramming of pacemakers so that underlying rhythm
could be manifest when assessing heart rate, it is unknown
whether the relationships between underlying heart rate and
CHQ-p or VAT would have been different in those patients
with a pacemaker. However, despite exclusion of paced
patients in the heart rate analysis, a large number of patients
without a pacemaker had bradycardia and were included in
the analysis, indicating that the results are reasonably appli-
cable to most Fontan patients. It is possible that the patients
with pacemakers may have had more profound bradycardia
than the bradycardic patients without pacemakers. Thus
excluding paced patients does not necessarily negate the
relationship between resting heart rate and outcome for
even the paced patients. Fourth, there was not a core labora-
tory for the ECG or exercise testing interpretation, so that in-
stitutional variability could have influenced the results. Fifth,
a definition of atrial tachycardia based on chart review, study
ECG, or exercise test may have underestimated the incidence
of this problem compared with methods such as 24-hour
ECG monitoring and electrophysiology study. Finally, asso-
ciations with VAT have to be interpreted cautiously inas-
much as only 311 patients had valid VATs reported. For
subjects who underwent exercise testing, those with a VAT
measurement had better physical functioning on CHQ than
those without a VAT measurement. In general, the analyses
of VAT as an outcome measure for Fontan subjects are based
on an older and possibly somewhat healthier cohort than the
other findings. Inability to reach VAT may be an important
determinant of functional outcome by itself.
Conclusions
In pediatric patients (6–18 years) after the Fontan procedure,
a lower resting heart rate and a higher peak heart rate during
exercise are each independently associated with improved
physical functional outcome as measured by the physical
component of the CHQ and the VAT. However, these correla-
tions are weak, suggesting that other, nonrhythm and nonrate,
factorsmayhave a greater impact on the functional outcomeof
pediatric patients undergoing the Fontan operation.
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